Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Su(var)3-9, Enhancer-of-zeste, and Trithorax (SET) domain-containing protein 8 (
SET8
) is the sole enzyme that monomethylates Lys-20 of histone H4 (H4K20).
SET8
has been implicated in the regulation of multiple biological processes, such as gene transcription, the cell cycle, and senescence.
SET8
quickly undergoes ubiquitination and degradation by several E3 ubiquitin ligases; however, the enzyme that deubiquitinates
SET8
has not yet been identified. Here we demonstrated that ubiquitin-specific peptidase 17-like family member (USP17) deubiquitinates and therefore stabilizes the
SET8
protein. We observed that USP17 interacts with
SET8
and removes
polyubiquitin
chains from
SET8
. USP17 knockdown not only decreased
SET8
protein levels and H4K20 monomethylation but also increased the levels of the cyclin-dependent kinase inhibitor p21. As a consequence, USP17 knockdown suppressed cell proliferation. We noted that USP17 was down-regulated in replicative senescence and that USP17 inhibition alone was sufficient to trigger cellular senescence. These results reveal a regulatory mechanism whereby USP17 prevents cellular senescence by removing ubiquitin marks from and stabilizing
SET8
and transcriptionally repressing
p21
.
...
PMID:The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing
p21
. 3153 87